PNEUMONIX MEDICAL RECEIVES NSF SBIR PHASE I GRANT

PneumoNIX Medical, a Baltimore-based medtech company focused on preventing complications associated with soft tissue biopsies, announced that it received Phase I SBIR grants from the NSF. The awards will aid with continued technical and business development of their novel device.